Global Pre-Menstrual Syndrome Market Growth (Status and Outlook) 2025-2031

September 2025 | 116 pages | ID: G13F3FE85218EN
LP Information

Abstracts

According to this study, the global Pre-Menstrual Syndrome market size will reach US$ million by 2031.

Pre-menstrual syndrome (PMS) is defined as a condition that affects women at childbearing age and is characterized by symptoms such as bloating, pain, breast tenderness, body pain, fatigue, mood fluctuation, anxiety, etc.

United States market for Pre-Menstrual Syndrome is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Pre-Menstrual Syndrome is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Pre-Menstrual Syndrome is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Pre-Menstrual Syndrome players cover Alva-Amco Pharmacal Cos., Inc., Bayer, Inc., Chattem, Inc. (Sanofi), DEKK-TEC, Inc., G. R. Lane Health Products Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Pre-Menstrual Syndrome Industry Forecast” looks at past sales and reviews total world Pre-Menstrual Syndrome sales in 2024, providing a comprehensive analysis by region and market sector of projected Pre-Menstrual Syndrome sales for 2025 through 2031. With Pre-Menstrual Syndrome sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pre-Menstrual Syndrome industry.

This Insight Report provides a comprehensive analysis of the global Pre-Menstrual Syndrome landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pre-Menstrual Syndrome portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pre-Menstrual Syndrome market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pre-Menstrual Syndrome and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pre-Menstrual Syndrome.

This report presents a comprehensive overview, market shares, and growth opportunities of Pre-Menstrual Syndrome market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Analgesics (Pain Killers)
• Oral Contraceptive Pills (OCPs)
• Gonadotropin-Releasing Hormone (GnRH)
• Antidepressants
• Ovarian Suppressors
• Diuretics
• Benzodiazepines

Segmentation by Application:

• Hospitals
• Clinic
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Alva-Amco Pharmacal Cos., Inc.
• Bayer, Inc.
• Chattem, Inc. (Sanofi)
• DEKK-TEC, Inc.
• G. R. Lane Health Products Ltd
• McNeil Consumer Healthcare
• MetP Pharma AG
• Pherin Pharmaceuticals, Inc.
• Umecrine Mood AB
• Novartis AG
• GlaxoSmithKline Plc

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Pre-Menstrual Syndrome Market Size (2020-2031)
  2.1.2 Pre-Menstrual Syndrome Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Pre-Menstrual Syndrome by Country/Region (2020, 2024 & 2031)
2.2 Pre-Menstrual Syndrome Segment by Type
  2.2.1 Analgesics (Pain Killers)
  2.2.2 Oral Contraceptive Pills (OCPs)
  2.2.3 Gonadotropin-Releasing Hormone (GnRH)
  2.2.4 Antidepressants
  2.2.5 Ovarian Suppressors
  2.2.6 Diuretics
  2.2.7 Benzodiazepines
2.3 Pre-Menstrual Syndrome Market Size by Type
  2.3.1 Pre-Menstrual Syndrome Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Pre-Menstrual Syndrome Market Size Market Share by Type (2020-2025)
2.4 Pre-Menstrual Syndrome Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinic
  2.4.3 Others
2.5 Pre-Menstrual Syndrome Market Size by Application
  2.5.1 Pre-Menstrual Syndrome Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Pre-Menstrual Syndrome Market Size Market Share by Application (2020-2025)

3 PRE-MENSTRUAL SYNDROME MARKET SIZE BY PLAYER

3.1 Pre-Menstrual Syndrome Market Size Market Share by Player
  3.1.1 Global Pre-Menstrual Syndrome Revenue by Player (2020-2025)
  3.1.2 Global Pre-Menstrual Syndrome Revenue Market Share by Player (2020-2025)
3.2 Global Pre-Menstrual Syndrome Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PRE-MENSTRUAL SYNDROME BY REGION

4.1 Pre-Menstrual Syndrome Market Size by Region (2020-2025)
4.2 Global Pre-Menstrual Syndrome Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pre-Menstrual Syndrome Market Size Growth (2020-2025)
4.4 APAC Pre-Menstrual Syndrome Market Size Growth (2020-2025)
4.5 Europe Pre-Menstrual Syndrome Market Size Growth (2020-2025)
4.6 Middle East & Africa Pre-Menstrual Syndrome Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Pre-Menstrual Syndrome Market Size by Country (2020-2025)
5.2 Americas Pre-Menstrual Syndrome Market Size by Type (2020-2025)
5.3 Americas Pre-Menstrual Syndrome Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Pre-Menstrual Syndrome Market Size by Region (2020-2025)
6.2 APAC Pre-Menstrual Syndrome Market Size by Type (2020-2025)
6.3 APAC Pre-Menstrual Syndrome Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Pre-Menstrual Syndrome Market Size by Country (2020-2025)
7.2 Europe Pre-Menstrual Syndrome Market Size by Type (2020-2025)
7.3 Europe Pre-Menstrual Syndrome Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Pre-Menstrual Syndrome by Region (2020-2025)
8.2 Middle East & Africa Pre-Menstrual Syndrome Market Size by Type (2020-2025)
8.3 Middle East & Africa Pre-Menstrual Syndrome Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PRE-MENSTRUAL SYNDROME MARKET FORECAST

10.1 Global Pre-Menstrual Syndrome Forecast by Region (2026-2031)
  10.1.1 Global Pre-Menstrual Syndrome Forecast by Region (2026-2031)
  10.1.2 Americas Pre-Menstrual Syndrome Forecast
  10.1.3 APAC Pre-Menstrual Syndrome Forecast
  10.1.4 Europe Pre-Menstrual Syndrome Forecast
  10.1.5 Middle East & Africa Pre-Menstrual Syndrome Forecast
10.2 Americas Pre-Menstrual Syndrome Forecast by Country (2026-2031)
  10.2.1 United States Market Pre-Menstrual Syndrome Forecast
  10.2.2 Canada Market Pre-Menstrual Syndrome Forecast
  10.2.3 Mexico Market Pre-Menstrual Syndrome Forecast
  10.2.4 Brazil Market Pre-Menstrual Syndrome Forecast
10.3 APAC Pre-Menstrual Syndrome Forecast by Region (2026-2031)
  10.3.1 China Pre-Menstrual Syndrome Market Forecast
  10.3.2 Japan Market Pre-Menstrual Syndrome Forecast
  10.3.3 Korea Market Pre-Menstrual Syndrome Forecast
  10.3.4 Southeast Asia Market Pre-Menstrual Syndrome Forecast
  10.3.5 India Market Pre-Menstrual Syndrome Forecast
  10.3.6 Australia Market Pre-Menstrual Syndrome Forecast
10.4 Europe Pre-Menstrual Syndrome Forecast by Country (2026-2031)
  10.4.1 Germany Market Pre-Menstrual Syndrome Forecast
  10.4.2 France Market Pre-Menstrual Syndrome Forecast
  10.4.3 UK Market Pre-Menstrual Syndrome Forecast
  10.4.4 Italy Market Pre-Menstrual Syndrome Forecast
  10.4.5 Russia Market Pre-Menstrual Syndrome Forecast
10.5 Middle East & Africa Pre-Menstrual Syndrome Forecast by Region (2026-2031)
  10.5.1 Egypt Market Pre-Menstrual Syndrome Forecast
  10.5.2 South Africa Market Pre-Menstrual Syndrome Forecast
  10.5.3 Israel Market Pre-Menstrual Syndrome Forecast
  10.5.4 Turkey Market Pre-Menstrual Syndrome Forecast
10.6 Global Pre-Menstrual Syndrome Forecast by Type (2026-2031)
10.7 Global Pre-Menstrual Syndrome Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Pre-Menstrual Syndrome Forecast

11 KEY PLAYERS ANALYSIS

11.1 Alva-Amco Pharmacal Cos., Inc.
  11.1.1 Alva-Amco Pharmacal Cos., Inc. Company Information
  11.1.2 Alva-Amco Pharmacal Cos., Inc. Pre-Menstrual Syndrome Product Offered
  11.1.3 Alva-Amco Pharmacal Cos., Inc. Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Alva-Amco Pharmacal Cos., Inc. Main Business Overview
  11.1.5 Alva-Amco Pharmacal Cos., Inc. Latest Developments
11.2 Bayer, Inc.
  11.2.1 Bayer, Inc. Company Information
  11.2.2 Bayer, Inc. Pre-Menstrual Syndrome Product Offered
  11.2.3 Bayer, Inc. Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Bayer, Inc. Main Business Overview
  11.2.5 Bayer, Inc. Latest Developments
11.3 Chattem, Inc. (Sanofi)
  11.3.1 Chattem, Inc. (Sanofi) Company Information
  11.3.2 Chattem, Inc. (Sanofi) Pre-Menstrual Syndrome Product Offered
  11.3.3 Chattem, Inc. (Sanofi) Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Chattem, Inc. (Sanofi) Main Business Overview
  11.3.5 Chattem, Inc. (Sanofi) Latest Developments
11.4 DEKK-TEC, Inc.
  11.4.1 DEKK-TEC, Inc. Company Information
  11.4.2 DEKK-TEC, Inc. Pre-Menstrual Syndrome Product Offered
  11.4.3 DEKK-TEC, Inc. Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 DEKK-TEC, Inc. Main Business Overview
  11.4.5 DEKK-TEC, Inc. Latest Developments
11.5 G. R. Lane Health Products Ltd
  11.5.1 G. R. Lane Health Products Ltd Company Information
  11.5.2 G. R. Lane Health Products Ltd Pre-Menstrual Syndrome Product Offered
  11.5.3 G. R. Lane Health Products Ltd Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 G. R. Lane Health Products Ltd Main Business Overview
  11.5.5 G. R. Lane Health Products Ltd Latest Developments
11.6 McNeil Consumer Healthcare
  11.6.1 McNeil Consumer Healthcare Company Information
  11.6.2 McNeil Consumer Healthcare Pre-Menstrual Syndrome Product Offered
  11.6.3 McNeil Consumer Healthcare Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 McNeil Consumer Healthcare Main Business Overview
  11.6.5 McNeil Consumer Healthcare Latest Developments
11.7 MetP Pharma AG
  11.7.1 MetP Pharma AG Company Information
  11.7.2 MetP Pharma AG Pre-Menstrual Syndrome Product Offered
  11.7.3 MetP Pharma AG Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 MetP Pharma AG Main Business Overview
  11.7.5 MetP Pharma AG Latest Developments
11.8 Pherin Pharmaceuticals, Inc.
  11.8.1 Pherin Pharmaceuticals, Inc. Company Information
  11.8.2 Pherin Pharmaceuticals, Inc. Pre-Menstrual Syndrome Product Offered
  11.8.3 Pherin Pharmaceuticals, Inc. Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Pherin Pharmaceuticals, Inc. Main Business Overview
  11.8.5 Pherin Pharmaceuticals, Inc. Latest Developments
11.9 Umecrine Mood AB
  11.9.1 Umecrine Mood AB Company Information
  11.9.2 Umecrine Mood AB Pre-Menstrual Syndrome Product Offered
  11.9.3 Umecrine Mood AB Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Umecrine Mood AB Main Business Overview
  11.9.5 Umecrine Mood AB Latest Developments
11.10 Novartis AG
  11.10.1 Novartis AG Company Information
  11.10.2 Novartis AG Pre-Menstrual Syndrome Product Offered
  11.10.3 Novartis AG Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Novartis AG Main Business Overview
  11.10.5 Novartis AG Latest Developments
11.11 GlaxoSmithKline Plc
  11.11.1 GlaxoSmithKline Plc Company Information
  11.11.2 GlaxoSmithKline Plc Pre-Menstrual Syndrome Product Offered
  11.11.3 GlaxoSmithKline Plc Pre-Menstrual Syndrome Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 GlaxoSmithKline Plc Main Business Overview
  11.11.5 GlaxoSmithKline Plc Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Pre-Menstrual Syndrome Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Pre-Menstrual Syndrome Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Analgesics (Pain Killers)
Table 4. Major Players of Oral Contraceptive Pills (OCPs)
Table 5. Major Players of Gonadotropin-Releasing Hormone (GnRH)
Table 6. Major Players of Antidepressants
Table 7. Major Players of Ovarian Suppressors
Table 8. Major Players of Diuretics
Table 9. Major Players of Benzodiazepines
Table 10. Pre-Menstrual Syndrome Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Pre-Menstrual Syndrome Market Size by Type (2020-2025) & ($ millions)
Table 12. Global Pre-Menstrual Syndrome Market Size Market Share by Type (2020-2025)
Table 13. Pre-Menstrual Syndrome Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 14. Global Pre-Menstrual Syndrome Market Size by Application (2020-2025) & ($ millions)
Table 15. Global Pre-Menstrual Syndrome Market Size Market Share by Application (2020-2025)
Table 16. Global Pre-Menstrual Syndrome Revenue by Player (2020-2025) & ($ millions)
Table 17. Global Pre-Menstrual Syndrome Revenue Market Share by Player (2020-2025)
Table 18. Pre-Menstrual Syndrome Key Players Head office and Products Offered
Table 19. Pre-Menstrual Syndrome Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Pre-Menstrual Syndrome Market Size by Region (2020-2025) & ($ millions)
Table 23. Global Pre-Menstrual Syndrome Market Size Market Share by Region (2020-2025)
Table 24. Global Pre-Menstrual Syndrome Revenue by Country/Region (2020-2025) & ($ millions)
Table 25. Global Pre-Menstrual Syndrome Revenue Market Share by Country/Region (2020-2025)
Table 26. Americas Pre-Menstrual Syndrome Market Size by Country (2020-2025) & ($ millions)
Table 27. Americas Pre-Menstrual Syndrome Market Size Market Share by Country (2020-2025)
Table 28. Americas Pre-Menstrual Syndrome Market Size by Type (2020-2025) & ($ millions)
Table 29. Americas Pre-Menstrual Syndrome Market Size Market Share by Type (2020-2025)
Table 30. Americas Pre-Menstrual Syndrome Market Size by Application (2020-2025) & ($ millions)
Table 31. Americas Pre-Menstrual Syndrome Market Size Market Share by Application (2020-2025)
Table 32. APAC Pre-Menstrual Syndrome Market Size by Region (2020-2025) & ($ millions)
Table 33. APAC Pre-Menstrual Syndrome Market Size Market Share by Region (2020-2025)
Table 34. APAC Pre-Menstrual Syndrome Market Size by Type (2020-2025) & ($ millions)
Table 35. APAC Pre-Menstrual Syndrome Market Size by Application (2020-2025) & ($ millions)
Table 36. Europe Pre-Menstrual Syndrome Market Size by Country (2020-2025) & ($ millions)
Table 37. Europe Pre-Menstrual Syndrome Market Size Market Share by Country (2020-2025)
Table 38. Europe Pre-Menstrual Syndrome Market Size by Type (2020-2025) & ($ millions)
Table 39. Europe Pre-Menstrual Syndrome Market Size by Application (2020-2025) & ($ millions)
Table 40. Middle East & Africa Pre-Menstrual Syndrome Market Size by Region (2020-2025) & ($ millions)
Table 41. Middle East & Africa Pre-Menstrual Syndrome Market Size by Type (2020-2025) & ($ millions)
Table 42. Middle East & Africa Pre-Menstrual Syndrome Market Size by Application (2020-2025) & ($ millions)
Table 43. Key Market Drivers & Growth Opportunities of Pre-Menstrual Syndrome
Table 44. Key Market Challenges & Risks of Pre-Menstrual Syndrome
Table 45. Key Industry Trends of Pre-Menstrual Syndrome
Table 46. Global Pre-Menstrual Syndrome Market Size Forecast by Region (2026-2031) & ($ millions)
Table 47. Global Pre-Menstrual Syndrome Market Size Market Share Forecast by Region (2026-2031)
Table 48. Global Pre-Menstrual Syndrome Market Size Forecast by Type (2026-2031) & ($ millions)
Table 49. Global Pre-Menstrual Syndrome Market Size Forecast by Application (2026-2031) & ($ millions)
Table 50. Alva-Amco Pharmacal Cos., Inc. Details, Company Type, Pre-Menstrual Syndrome Area Served and Its Competitors
Table 51. Alva-Amco Pharmacal Cos., Inc. Pre-Menstrual Syndrome Product Offered
Table 52. Alva-Amco Pharmacal Cos., Inc. Pre-Menstrual Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Alva-Amco Pharmacal Cos., Inc. Main Business
Table 54. Alva-Amco Pharmacal Cos., Inc. Latest Developments
Table 55. Bayer, Inc. Details, Company Type, Pre-Menstrual Syndrome Area Served and Its Competitors
Table 56. Bayer, Inc. Pre-Menstrual Syndrome Product Offered
Table 57. Bayer, Inc. Pre-Menstrual Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Bayer, Inc. Main Business
Table 59. Bayer, Inc. Latest Developments
Table 60. Chattem, Inc. (Sanofi) Details, Company Type, Pre-Menstrual Syndrome Area Served and Its Competitors
Table 61. Chattem, Inc. (Sanofi) Pre-Menstrual Syndrome Product Offered
Table 62. Chattem, Inc. (Sanofi) Pre-Menstrual Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Chattem, Inc. (Sanofi) Main Business
Table 64. Chattem, Inc. (Sanofi) Latest Developments
Table 65. DEKK-TEC, Inc. Details, Company Type, Pre-Menstrual Syndrome Area Served and Its Competitors
Table 66. DEKK-TEC, Inc. Pre-Menstrual Syndrome Product Offered
Table 67. DEKK-TEC, Inc. Pre-Menstrual Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. DEKK-TEC, Inc. Main Business
Table 69. DEKK-TEC, Inc. Latest Developments
Table 70. G. R. Lane Health Products Ltd Details, Company Type, Pre-Menstrual Syndrome Area Served and Its Competitors
Table 71. G. R. Lane Health Products Ltd Pre-Menstrual Syndrome Product Offered
Table 72. G. R. Lane Health Products Ltd Pre-Menstrual Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. G. R. Lane Health Products Ltd Main Business
Table 74. G. R. Lane Health Products Ltd Latest Developments
Table 75. McNeil Consumer Healthcare Details, Company Type, Pre-Menstrual Syndrome Area Served and Its Competitors
Table 76. McNeil Consumer Healthcare Pre-Menstrual Syndrome Product Offered
Table 77. McNeil Consumer Healthcare Pre-Menstrual Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. McNeil Consumer Healthcare Main Business
Table 79. McNeil Consumer Healthcare Latest Developments
Table 80. MetP Pharma AG Details, Company Type, Pre-Menstrual Syndrome Area Served and Its Competitors
Table 81. MetP Pharma AG Pre-Menstrual Syndrome Product Offered
Table 82. MetP Pharma AG Pre-Menstrual Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. MetP Pharma AG Main Business
Table 84. MetP Pharma AG Latest Developments
Table 85. Pherin Pharmaceuticals, Inc. Details, Company Type, Pre-Menstrual Syndrome Area Served and Its Competitors
Table 86. Pherin Pharmaceuticals, Inc. Pre-Menstrual Syndrome Product Offered
Table 87. Pherin Pharmaceuticals, Inc. Pre-Menstrual Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Pherin Pharmaceuticals, Inc. Main Business
Table 89. Pherin Pharmaceuticals, Inc. Latest Developments
Table 90. Umecrine Mood AB Details, Company Type, Pre-Menstrual Syndrome Area Served and Its Competitors
Table 91. Umecrine Mood AB Pre-Menstrual Syndrome Product Offered
Table 92. Umecrine Mood AB Pre-Menstrual Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Umecrine Mood AB Main Business
Table 94. Umecrine Mood AB Latest Developments
Table 95. Novartis AG Details, Company Type, Pre-Menstrual Syndrome Area Served and Its Competitors
Table 96. Novartis AG Pre-Menstrual Syndrome Product Offered
Table 97. Novartis AG Pre-Menstrual Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Novartis AG Main Business
Table 99. Novartis AG Latest Developments
Table 100. GlaxoSmithKline Plc Details, Company Type, Pre-Menstrual Syndrome Area Served and Its Competitors
Table 101. GlaxoSmithKline Plc Pre-Menstrual Syndrome Product Offered
Table 102. GlaxoSmithKline Plc Pre-Menstrual Syndrome Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. GlaxoSmithKline Plc Main Business
Table 104. GlaxoSmithKline Plc Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Pre-Menstrual Syndrome Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pre-Menstrual Syndrome Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Pre-Menstrual Syndrome Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Pre-Menstrual Syndrome Sales Market Share by Country/Region (2024)
Figure 8. Pre-Menstrual Syndrome Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Pre-Menstrual Syndrome Market Size Market Share by Type in 2024
Figure 10. Pre-Menstrual Syndrome in Hospitals
Figure 11. Global Pre-Menstrual Syndrome Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Pre-Menstrual Syndrome in Clinic
Figure 13. Global Pre-Menstrual Syndrome Market: Clinic (2020-2025) & ($ millions)
Figure 14. Pre-Menstrual Syndrome in Others
Figure 15. Global Pre-Menstrual Syndrome Market: Others (2020-2025) & ($ millions)
Figure 16. Global Pre-Menstrual Syndrome Market Size Market Share by Application in 2024
Figure 17. Global Pre-Menstrual Syndrome Revenue Market Share by Player in 2024
Figure 18. Global Pre-Menstrual Syndrome Market Size Market Share by Region (2020-2025)
Figure 19. Americas Pre-Menstrual Syndrome Market Size 2020-2025 ($ millions)
Figure 20. APAC Pre-Menstrual Syndrome Market Size 2020-2025 ($ millions)
Figure 21. Europe Pre-Menstrual Syndrome Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Pre-Menstrual Syndrome Market Size 2020-2025 ($ millions)
Figure 23. Americas Pre-Menstrual Syndrome Value Market Share by Country in 2024
Figure 24. United States Pre-Menstrual Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Pre-Menstrual Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Pre-Menstrual Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Pre-Menstrual Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Pre-Menstrual Syndrome Market Size Market Share by Region in 2024
Figure 29. APAC Pre-Menstrual Syndrome Market Size Market Share by Type (2020-2025)
Figure 30. APAC Pre-Menstrual Syndrome Market Size Market Share by Application (2020-2025)
Figure 31. China Pre-Menstrual Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Pre-Menstrual Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Pre-Menstrual Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Pre-Menstrual Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 35. India Pre-Menstrual Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Pre-Menstrual Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Pre-Menstrual Syndrome Market Size Market Share by Country in 2024
Figure 38. Europe Pre-Menstrual Syndrome Market Size Market Share by Type (2020-2025)
Figure 39. Europe Pre-Menstrual Syndrome Market Size Market Share by Application (2020-2025)
Figure 40. Germany Pre-Menstrual Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 41. France Pre-Menstrual Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Pre-Menstrual Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Pre-Menstrual Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Pre-Menstrual Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Pre-Menstrual Syndrome Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Pre-Menstrual Syndrome Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Pre-Menstrual Syndrome Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Pre-Menstrual Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Pre-Menstrual Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Pre-Menstrual Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Pre-Menstrual Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Pre-Menstrual Syndrome Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Pre-Menstrual Syndrome Market Size 2026-2031 ($ millions)
Figure 54. APAC Pre-Menstrual Syndrome Market Size 2026-2031 ($ millions)
Figure 55. Europe Pre-Menstrual Syndrome Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Pre-Menstrual Syndrome Market Size 2026-2031 ($ millions)
Figure 57. United States Pre-Menstrual Syndrome Market Size 2026-2031 ($ millions)
Figure 58. Canada Pre-Menstrual Syndrome Market Size 2026-2031 ($ millions)
Figure 59. Mexico Pre-Menstrual Syndrome Market Size 2026-2031 ($ millions)
Figure 60. Brazil Pre-Menstrual Syndrome Market Size 2026-2031 ($ millions)
Figure 61. China Pre-Menstrual Syndrome Market Size 2026-2031 ($ millions)
Figure 62. Japan Pre-Menstrual Syndrome Market Size 2026-2031 ($ millions)
Figure 63. Korea Pre-Menstrual Syndrome Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Pre-Menstrual Syndrome Market Size 2026-2031 ($ millions)
Figure 65. India Pre-Menstrual Syndrome Market Size 2026-2031 ($ millions)
Figure 66. Australia Pre-Menstrual Syndrome Market Size 2026-2031 ($ millions)
Figure 67. Germany Pre-Menstrual Syndrome Market Size 2026-2031 ($ millions)
Figure 68. France Pre-Menstrual Syndrome Market Size 2026-2031 ($ millions)
Figure 69. UK Pre-Menstrual Syndrome Market Size 2026-2031 ($ millions)
Figure 70. Italy Pre-Menstrual Syndrome Market Size 2026-2031 ($ millions)
Figure 71. Russia Pre-Menstrual Syndrome Market Size 2026-2031 ($ millions)
Figure 72. Egypt Pre-Menstrual Syndrome Market Size 2026-2031 ($ millions)
Figure 73. South Africa Pre-Menstrual Syndrome Market Size 2026-2031 ($ millions)
Figure 74. Israel Pre-Menstrual Syndrome Market Size 2026-2031 ($ millions)
Figure 75. Turkey Pre-Menstrual Syndrome Market Size 2026-2031 ($ millions)
Figure 76. Global Pre-Menstrual Syndrome Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Pre-Menstrual Syndrome Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Pre-Menstrual Syndrome Market Size 2026-2031 ($ millions)